{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:02:58Z","timestamp":1791921778264,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.cgh.2022.09.014","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T01:40:14Z","timestamp":1663810814000},"page":"1873-1880.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Nonalcoholic Fatty Liver Disease Without Metabolic-associated Fatty Liver Disease and the Risk of Metabolic Syndrome"],"prefix":"10.1016","volume":"21","author":[{"given":"Dong Hyun","family":"Sinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danbee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Chul","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Soo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliseo","family":"Guallar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yewan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6453-3450","authenticated-orcid":false,"given":"Geum-Youn","family":"Gwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2022.09.014_bib1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2022.09.014_bib2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/liv.14478","article-title":"What's in a name? Renaming \u2018NAFLD\u2019 to \u2018MAFLD\u2019","volume":"40","author":"Fouad","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2022.09.014_bib3","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.09.014_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.292.6512.13","article-title":"Ultrasound scanning in the detection of hepatic fibrosis and steatosis","volume":"292","author":"Saverymuttu","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.cgh.2022.09.014_bib5","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cgh.2022.09.014_bib6","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jhep.2021.07.035","article-title":"Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States","volume":"75","author":"Kim","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.09.014_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/liv.15139","article-title":"Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta-analysis: focusing on the non-overlap groups","volume":"42","author":"Ayada","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2022.09.014_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/liv.15142","article-title":"Meaning of non-overlapping patients between the MAFLD and NAFLD definitions","volume":"42","author":"Chan","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2022.09.014_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jhep.2021.09.002","article-title":"NAFLD vs. MAFLD - It is not the name but the disease that decides the outcome in fatty liver","volume":"76","author":"De","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.09.014_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245762","article-title":"Outcomes of NAFLD and MAFLD: results from a community-based, prospective cohort study","volume":"16","author":"Niriella","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2022.09.014_bib11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ajg.2011.400","article-title":"Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults","volume":"107","author":"Sinn","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2022.09.014_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/gutjnl-2016-311854","article-title":"Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study","volume":"66","author":"Sinn","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2022.09.014_bib13","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jhep.2017.08.024","article-title":"Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: a cohort study","volume":"67","author":"Sinn","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.09.014_bib14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/jgh.14856","article-title":"Non-alcoholic fatty liver disease and the incidence of myocardial infarction: a cohort study","volume":"35","author":"Sinn","year":"2020","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.09.014_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1530\/EJE-19-0143","article-title":"Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study","volume":"181","author":"Sinn","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cgh.2022.09.014_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3350\/cmh.2021.0178","article-title":"Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of nonalcoholic fatty liver disease","volume":"27","author":"Kang","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2022.09.014_bib17","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1053\/j.gastro.2020.11.051","article-title":"AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: expert review","volume":"160","author":"Younossi","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.09.014_bib18","doi-asserted-by":"crossref","first-page":"e529","DOI":"10.1097\/MEG.0000000000002158","article-title":"Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease","volume":"33","author":"Sinn","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.09.014_bib19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2016.06.001","article-title":"Persistent nonalcoholic fatty liver disease increases risk for carotid atherosclerosis","volume":"151","author":"Sinn","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.09.014_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3350\/cmh.2021.0067","article-title":"From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: big wave or ripple?","volume":"27","author":"Kang","year":"2021","journal-title":"Clin Mol Hepatol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356522009120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356522009120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:42:09Z","timestamp":1761543729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356522009120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1542356522009120"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2022.09.014","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonalcoholic Fatty Liver Disease Without Metabolic-associated Fatty Liver Disease and the Risk of Metabolic Syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2022.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the AGA Institute","name":"copyright","label":"Copyright"}]}}